Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smokers in south asia get a new ally: pharmacists with graphic warning booklets

NCT ID NCT07098065

Disease control Sponsor: Hitotsubashi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether showing smokers graphic health warnings (like pictures of diseased lungs) along with personalized advice from a pharmacist can help them quit. About 3,400 adult smokers in Bangladesh and Pakistan will be split into three groups: one gets only the warning booklets, another gets booklets plus counseling and SMS reminders, and a third gets usual pharmacy care. The main goal is to see how many people stop smoking for at least a week after 12 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
graphic health warnings and pharmacist-led counseling
What this could lead to
If successful, this could provide a low-cost, scalable way to help smokers quit and reduce chronic diseases like heart disease and diabetes in resource-limited settings.
What could go wrong
This is a behavioral intervention, not a drug, so results depend on participant motivation and follow-up. The trial is still recruiting, and the primary outcome is self-reported, which may be less reliable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 3,400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 and older * Adults (≥18 years) who are current smokers (daily or occasional) and regular visitors to participating pharmacies. * Permanent resident of the study area, * Access to mobile phone * Able to operate smartphone or tablet. Exclusion Criteria: * Without pregnancy and lactation * Without cognitive or psychiatric conditions, * Without severe medical conditions, * Participation in other studies, and inability to consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health warning label are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hypertensive disorder Noncommunicable Diseases Tobacco Use Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Health warning label Hypertension Non-communicable chronic diseases Tobacco cessation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Global Public Health Research Foundation

    RECRUITING

    Dhaka, Bangladesh

More trials for these conditions

Other studies related to the condition(s) this trial covers.